Free Trial
→ This Bull Market Indicator called NVDA at $116 (From WealthPress) (Ad) Free GALT Stock Alerts

Galectin Therapeutics (GALT) Insider Trading & Ownership

Galectin Therapeutics logo
$2.82 +0.06 (+2.18%)
(As of 11/20/2024 ET)
Compare

Galectin Therapeutics (NASDAQ:GALT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
52.70%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$34,100.70
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$65,248.38
Get GALT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Galectin Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GALT Insider Buying and Selling by Quarter

Ad Weiss Ratings
Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
This could be his favorite coin.

Galectin Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/23/2024Kary EldredDirectorBuy500$2.60$1,300.00  
10/16/2024Kevin D FreemanDirectorBuy5,000$2.70$13,500.00  
8/23/2024Richard A Jr. ZordaniDirectorBuy1,759$2.30$4,045.70  
4/30/2024Richard A Jr. ZordaniDirectorBuy1,000$3.52$3,520.00  
4/24/2024Joel LewisCEOBuy1,000$3.39$3,390.00  
4/22/2024James C CzirrMajor ShareholderSell21,323$3.06$65,248.38  
4/22/2024Kevin D FreemanDirectorBuy2,500$2.98$7,450.00  
1/16/2024Kary EldredDirectorBuy500$1.79$895.00  
(Data available from 1/1/2013 forward)

GALT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Galectin Therapeutics includes Elissa J Schwartz, Fund L.P. 10X, Jack W Callicutt, James C Czirr, Joel Lewis, Kary Eldred, Kevin D Freeman, and Richard A Jr. Zordani. Learn more on insiders at GALT.

52.70% of Galectin Therapeutics stock is owned by insiders. Learn more on GALT's insider holdings.

The following insiders have purchased GALT shares in the last 24 months: Joel Lewis ($4,910.00), Kary Eldred ($8,088.42), Kevin D Freeman ($20,950.00), and Richard A Jr. Zordani ($7,565.70).

Insiders have purchased a total of 17,157 GALT shares in the last 24 months for a total of $41,514.12 bought.

The following insider sold GALT shares in the last 24 months: James C Czirr ($65,248.38).

Insiders have sold a total of 21,323 Galectin Therapeutics shares in the last 24 months for a total of $65,248.38 sold.

Galectin Therapeutics Key Executives

  • Mr. Joel Lewis (Age 54)
    President, CEO & Director
    Compensation: $907.72k
  • Mr. Jack W. Callicutt CPA (Age 57)
    CFO, Treasurer & Corporate Secretary
    Compensation: $521.47k
  • Dr. Pol F. Boudes M.D. (Age 67)
    Ph.D., Chief Medical Officer
    Compensation: $730.33k
  • Robert Tritt
    General Counsel
  • Mr. Jeff Katstra
    Head of CMC & Pharmaceutical Development
  • Ms. Beth Knowles
    Executive Assistant & Officer Manager

Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:GALT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners
Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time N...
Behind the Markets | Sponsored